Yihong Ni
Overview
Explore the profile of Yihong Ni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Z, Yu Q, Wang X, Ni Y, Su K, Zhang J, et al.
J Vis Exp
. 2024 Nov;
(212).
PMID: 39494866
The increasing scarcity of donor lungs for transplantation has spurred significant interest in the utilization of organs procured from donors after cardiac death (DCD). However, a critical challenge remains in...
2.
Chen F, Wang Z, Gu X, Ni Y, Qiang G
J Thorac Dis
. 2024 Jun;
16(5):2822-2834.
PMID: 38883611
Background: Several studies have shown that surgery may improve prognosis in patients with limited-stage small cell lung cancer (LS-SCLC). This study aimed to compare the effects of different treatment modalities...
3.
Chen F, Ni Y, Zhang J, Hao Y, Tian Z, Qiang G
J Int Med Res
. 2023 Sep;
51(9):3000605231199763.
PMID: 37751487
Objective: To conduct a systematic review and meta-analysis evaluating the diagnostic value of folate receptor-positive (FR+) circulating tumour cells (CTCs) as a potential tumour marker for lung cancer diagnosis. Methods:...
4.
Zhou X, Wang Z, Ni Y, Yu Y, Wang G, Chen L
Am J Transl Res
. 2020 Apr;
12(3):731-742.
PMID: 32269708
Oxidative stress can trigger DNA damage response and activation of cellular senescence. Accumulating studies have demonstrated that senescent cells can produce senescence-associated secretory phenotype that leads to increased bone resorption...
5.
Zhang Y, Ren L, Zheng F, Zhuang X, Jiang D, Chen S, et al.
J Int Med Res
. 2020 Mar;
48(3):300060519897483.
PMID: 32212874
No abstract available.
6.
Xu Y, Zhou Q, Feng X, Dai Y, Jiang Y, Jiang W, et al.
Biomed Pharmacother
. 2020 Mar;
126:110048.
PMID: 32145587
Disulfiram (DSF) is an FDA approved anti-alcoholism drug in use for more than 60 years. Recently, antitumor activity of the DSF/copper (DSF/Cu) complex has been identified. Its anti-multiple myeloma activity,...
7.
Xiao F, Jiang Y, Wang X, Jiang W, Wang L, Zhuang X, et al.
Int J Clin Exp Pathol
. 2020 Jan;
11(2):537-547.
PMID: 31938139
Neutrophil extracellular traps (NETs) are shown to play important roles in the progression or development of systemic autoimmune diseases. However, implication of NETs or NETosis in the pathogenesis of non-systemic...
8.
Pan Z, Wang J, Xu M, Chen S, Li X, Sun A, et al.
Mol Med Rep
. 2019 Sep;
20(5):4119-4124.
PMID: 31545435
Aberrant lipid metabolism contributes to the development of type 2 diabetes mellitus. The mechanisms by which hydrogen sulfide (H2S), an endogenous gasotransmitter, regulates lipid metabolism remain unclear. The aim of...
9.
Wang X, Qin A, Xiao F, Olatunji O, Zhang S, Pan D, et al.
J Food Biochem
. 2019 Jul;
43(2):e12727.
PMID: 31353654
This study investigated the kidney-protective ability of N -(2-hydroxyethyl)-adenosine (HEA) in alloxan-induced diabetic rats. Diabetes was induced in the rats by the administration of alloxan monohydrate (150 mg/kg, i.p) and...
10.
Wu P, Zhao Y, Zhuang X, Sun A, Zhang Y, Ni Y
Clin Neurol Neurosurg
. 2018 Oct;
174:203-206.
PMID: 30273843
Objectives: To reveal potential association between glucagon-like peptide 1 (GLP-1) concentration in serum and mild cognitive function impairment (MCI) in type 2 diabetes mellitus (T2DM) patients. Patients And Methods: A...